Market Overview:
The global cisatracurium besylate API market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for general anesthesia and tracheal intubation applications, and the rising number of surgical procedures. In addition, the growing geriatric population is also contributing to the growth of this market. However, factors such as high product prices and stringent regulatory requirements are restraining its growth. Based on type, the global cisatracurium besylate API market can be segmented into purity:≥ 97% and purity:≥ 99%. The purity:≥ 97% segment is expected to account for a larger share of this market during the forecast period owing to its lower price point as compared with other types of cisatracurium besylate APIs. Based on application, this market can be divided into general anesthesia, tracheal intubation, and others (including neuromuscular blockade). General anesthesia accounted for a major share of this market in 2017 owing to its widespread use in various surgeries. By region, North America was estimated to account for a leading share of this global market in 2017 due To increased demand from countries such as Canada and Mexico .
Product Definition:
Cisatracurium Besylate API is a muscle relaxant. It is used to help with anesthesia during surgery or other medical procedures.
Purity:≥ 97%:
Purity: 97%, it's usage.
The global cisatracurium besylate API market size was valued at USD 548.1 million in 2016. It is expected to witness a significant rise owing to the growing pharmaceutical industry, increasing demand for generic drugs, and rising use of medicines across the world especially in emerging economies such as China & India.
Purity:≥ 99%:
Cisatracurium Besylate is a prescription drug used for the treatment of muscle spasms caused by multiple sclerosis, Parkinson's disease, and epilepsy. It is also used as an anti-epileptic drug to prevent seizures in people suffering from epilepsy. Cisatracurium besylate injection is manufactured by the neutralization of a sulfuric acid salt formed when bromine (as halides) and saturated fat are reactivated with phosphoric acid.
Application Insights:
The general anesthesia segment dominated the global market in terms of revenue share in 2017. The high share is attributable to increasing usage of the drug for sedation and relaxation during surgical procedures. However, other factors such as rising prevalence of obesity and cardiovascular diseases may also be contributing to this growth.
In terms of revenue, tracheal intubation application is anticipated to witness a CAGR around 10% from 2018 to 2030 owing to growing awareness about respiratory problems among children and rise in number of surgeries requiring tracheal intubation over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to witness a rise in demand for cisatracurium besylate API over the forecast period owing to increasing cases of cardiac arrest, respiratory failure, and other trauma cases. In addition, increasing use of general anesthesia coupled with rising awareness about alternatives such as conscious sedation and rapid recovery sleep is also anticipated to drive growth.
Asia Pacific is expected to be one of the fastest growing regions during the forecast period due to various factors such as improving healthcare infrastructure and growing medical tourism industry in emerging countries like India & China & Malaysia etc.; which will lead towards an increase in demand for various medical products including drugs.
Growth Factors:
- Increasing geriatric population: The global geriatric population is increasing at a rapid pace and this is expected to drive the demand for Cisatracurium Besylate API in the coming years.
- Growing number of surgeries: The number of surgeries being performed across the world is increasing rapidly and this is expected to create a strong demand for Cisatracurium Besylate API in the near future.
- Rising prevalence of chronic diseases: The prevalence of chronic diseases such as cancer, heart disease, and diabetes is rising at an alarming rate and this is likely to boost the demand for Cisatracurium Besylate API in the coming years.
- Technological advancements: There has been a significant advancement in medical technology over the past few years and this has led to an increase in surgical procedures being performed worldwide. This will create a strong demand for Cisatracurium Besylate API in upcoming years . 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Cisatracurium Besylate API Market Research Report
By Type
Purity:≥ 97%, Purity:≥ 99%
By Application
General Anesthesia, Tracheal Intubation, Others
By Companies
Teva Pharmaceutical Industries, Wavelength Pharmaceuticals, Farmhispania Group, Guike Pharmaceutical, Jiangsu Hengrui, YONSUNG Fine Chemicals, Lianyungang Norsen
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Cisatracurium Besylate API Market Report Segments:
The global Cisatracurium Besylate API market is segmented on the basis of:
Types
Purity:≥ 97%, Purity:≥ 99%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
General Anesthesia, Tracheal Intubation, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Teva Pharmaceutical Industries
- Wavelength Pharmaceuticals
- Farmhispania Group
- Guike Pharmaceutical
- Jiangsu Hengrui
- YONSUNG Fine Chemicals
- Lianyungang Norsen
Highlights of The Cisatracurium Besylate API Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity:≥ 97%
- Purity:≥ 99%
- By Application:
- General Anesthesia
- Tracheal Intubation
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cisatracurium Besylate API Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cisatracurium Besylate API is a prescription medication used to relax muscles. It is also known by the trade name Atracurium.
Some of the major companies in the cisatracurium besylate api market are Teva Pharmaceutical Industries, Wavelength Pharmaceuticals, Farmhispania Group, Guike Pharmaceutical, Jiangsu Hengrui, YONSUNG Fine Chemicals, Lianyungang Norsen.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cisatracurium Besylate API Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Cisatracurium Besylate API Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Cisatracurium Besylate API Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Cisatracurium Besylate API Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Cisatracurium Besylate API Market Size & Forecast, 2020-2028 4.5.1 Cisatracurium Besylate API Market Size and Y-o-Y Growth 4.5.2 Cisatracurium Besylate API Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Purity:≥ 97%
5.2.2 Purity:≥ 99%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 General Anesthesia
6.2.2 Tracheal Intubation
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cisatracurium Besylate API Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cisatracurium Besylate API Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Purity:≥ 97%
9.6.2 Purity:≥ 99%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 General Anesthesia
9.10.2 Tracheal Intubation
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Purity:≥ 97%
10.6.2 Purity:≥ 99%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 General Anesthesia
10.10.2 Tracheal Intubation
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Purity:≥ 97%
11.6.2 Purity:≥ 99%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 General Anesthesia
11.10.2 Tracheal Intubation
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Purity:≥ 97%
12.6.2 Purity:≥ 99%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 General Anesthesia
12.10.2 Tracheal Intubation
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Purity:≥ 97%
13.6.2 Purity:≥ 99%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 General Anesthesia
13.10.2 Tracheal Intubation
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cisatracurium Besylate API Market: Competitive Dashboard
14.2 Global Cisatracurium Besylate API Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Teva Pharmaceutical Industries
14.3.2 Wavelength Pharmaceuticals
14.3.3 Farmhispania Group
14.3.4 Guike Pharmaceutical
14.3.5 Jiangsu Hengrui
14.3.6 YONSUNG Fine Chemicals
14.3.7 Lianyungang Norsen